ArticleBMC medical imaging2025
Comparative analysis of the DCNN and HFCNN Based Computerized detection of liver cancer.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Targeting mitochondrial dysfunction to intervene in liver cancer.Cancer biology & medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Liver cancer detection is critically important in the discipline of biomedical image testing and diagnosis. Researchers have explored numerous machine learning (ML) techniques and deep learning (DL) approaches aimed at the automated recognition of liver disease by analysing computed tomography (CT) images. This study compares two frameworks, Deep Convolutional Neural Network (DCNN) and Hierarchical Fusion Convolutional Neural Networks (HFCNN), to assess their effectiveness in liver cancer segmentation. The contribution includes enhancing the edges and textures of CT images through filtering to achieve precise liver segmentation. Additionally, an existing DL framework was employed for liver cancer detection and segmentation. The strengths of this paper include a clear emphasis on the criticality of liver cancer detection in biomedical imaging and diagnostics. It also highlights the challenges associated with CT image detection and segmentation and provides a comprehensive summary of recent literature. However, certain difficulties arise during the detection process in CT images due to overlapping structures, such as bile ducts, blood vessels, image noise, textural changes, size and location variations, and inherent heterogeneity. These factors may lead to segmentation errors and subsequently different analyses. This research analysis compares two advanced methodologies, DCNN and HFCNN, for liver cancer detection. The evaluation of DCNN and HFCNN in liver cancer detection is conducted using multiple performance metrics, including precision, F1-score, recall, and accuracy. This comprehensive assessment provides a detailed evaluation of these models' effectiveness compared to other state-of-the-art methods in identifying liver cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.